Nacuda, Baby Bou .

HRN: 21-99-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2022
AMPICILLIN 250MG (VIAL)
10/08/2022
10/15/2022
IV
160mg
Q12
PSNB; PROM X 19hrs
Waiting Final Action 
10/08/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
10/08/2022
10/15/2022
IVT
16mg
Q24
PSnB; PrOm X19hrs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: